Vermillion’s (Nasdaq: VRML) annual revenue up

Orlando, Fl 3/27/12 (StreetBeat) -- Vermillion Inc. (Nasdaq: VRML) reported a $3.1 million net loss on $868,000 revenue during the fourth quarter ended Dec. 31, versus $4 million on $345,000 revenue during the same three months the year before.

For fiscal 2011, the Austin-based molecular diagnostics company posted a $17.8 million net loss on $1.9 million revenue compared to a $19 million net loss on $1.2 million revenue during the previous fiscal year.

Shares were trading for about $1.78 Tuesday morning.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly